Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Trial details
- Registry ID
- NCT06456593
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseNCT06456593 | ABVX | Phase 2 | Recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |